Epilepsy surgery in patients with malformations of cortical development

• Published in: Current opinion in neurology Vol. 19; no. 2; p. 169
• Main Authors: Lüders, Hans, Schuele, Stephan U
• Format: Journal Article
• Language: English
• Published: England 01.04.2006
• Subjects: Brain Diseases - complications; Cerebral Cortex - abnormalities; Cerebral Cortex - surgery; Diagnostic Imaging - classification; Diagnostic Imaging - methods; Electroencephalography; Epilepsy - etiology; Epilepsy - surgery; Humans; Neurosurgical Procedures - methods; Treatment Outcome
• ISSN: 1350-7540
• DOI: 10.1097/01.wco.0000218234.67840.cb

Patients with malformations of cortical development often suffer from intractable focal epilepsy. This review considers recent progress in the selection and seizure outcome of patients undergoing resective epilepsy surgery for this condition. Patients with malformations of cortical development restricted to part or even a whole hemisphere may be candidates for epilepsy surgery even when, due to microscopic malformations, magnetic resonance imaging shows no detectable lesion. Despite recent advances in structural and functional imaging, the majority of patients with this condition undergo invasive evaluation. Patients with focal cortical dysplasia, with and without a detectable lesion on magnetic resonance imaging, often have a favorable outcome with epilepsy surgery. The underlying pathological substrate seems to be a better predictor for surgical outcome in patients with focal cortical dysplasia than the presence of a lesion on magnetic resonance imaging. Epilepsy surgery can be offered in a highly selected subgroup of patients with unilateral nodular heterotopia. Seizures in hemimegalencephaly may respond favorably to hemispherectomy, although most children will continue to have seizures and significant functional impairments. Patients with focal epilepsy due to malformations of cortical development are often intractable to medical management. Resective epilepsy surgery can be beneficial, particularly for patients with focal cortical dysplasia and unilateral hemispheric malformations.